Author:
Jantunen E,Putkonen M,Nousiainen T,Pelliniemi T-T,Mahlamäki E,Remes K
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference20 articles.
1. Attal M, Harousseau JL, Stoppa AM et al. High-dose therapy in multiple myeloma: a prospective randomized study of the Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91–97.
2. Barlogie B, Jagannath S, Vesole D et al. Superiority of tandem autologous transplantation over standard chemotherapy for previously untreated multiple myeloma. Blood 1997; 89: 789–793.
3. Lenhoff S, Hjorth M, Holmberg E et al. Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population based study. Blood 2000; 95: 7–11.
4. Gratwohl A, Passweg J, Baldomero H et al. Hematopoietic stem cell transplantation activity in Europe 1999. Bone Marrow Transplant 2001; 27: 899–916.
5. Kotasek D, Shepherd KM, Sage RE et al. Factors affecting stem cell collections in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11–17.